Showing 521 - 540 results of 101,602 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( 5 ((w decrease) OR (we decrease)) ))', query time: 1.80s Refine Results
  1. 521
  2. 522
  3. 523
  4. 524

    NaSal increased the excitability of 5-HTergic neurons, but decreased that of GABAergic neurons in the DRN of the ChR2 transgenic mouse. by Yan Jin (143500)

    Published 2015
    “…(D) Sample traces (left panel) and group data (right panel, paired Student’s <i>t</i>-test) showing that NaSal suppressed the firing of GABAergic neurons evoked by laser light (1 s, 5.5 mW, 473 nm). (E) Sample recordings from a GABAergic neuron showing that NaSal decreased voltage responses to a series of hyperpolarizing currents (-10 to -60 pA, -10 pA/step, duration: 500 ms). …”
  5. 525
  6. 526
  7. 527
  8. 528
  9. 529
  10. 530

    Multiple C–H Activations of Linear Alkanes by Various (η<sup>5</sup>‑Cyclopentadienyl)W(NO)(CH<sub>2</sub>CMe<sub>3</sub>)<sub>2</sub> Complexes by Monica V. Shree (4092343)

    Published 2017
    “…As illustrated in the accompanying diagram, thermolysis of Cp*W­(NO)­(CH<sub>2</sub>CMe<sub>3</sub>)<sub>2</sub> (Cp* = η<sup>5</sup>-C<sub>5</sub>Me<sub>5</sub>) at 80 °C in neat linear alkanes effects three successive C–H bond activations of the hydrocarbon substrates and forms Cp*W­(NO)­(H)­(η<sup>3</sup>-allyl) complexes in which the allyl ligands are derived from the alkanes. …”
  11. 531

    Data_Sheet_1_Microclimatic Warming Leads to a Decrease in Species and Growth Form Diversity: Insights From a Tropical Alpine Grassland.PDF by Sisimac A. Duchicela (11503918)

    Published 2021
    “…We installed five monitoring blocks in 2012 at ca. 4,200 m asl with 20 OTCs and 50 control plots randomly distributed within each block. …”
  12. 532
  13. 533

    Image5_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
  14. 534
  15. 535
  16. 536
  17. 537
  18. 538
  19. 539
  20. 540